placeholder image
B. H. Fireman All authors
About
Publications
selected publications
Journal Article
  • Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA vaccination in preventing COVID-19-associated emergency department and urgent care encounters and hospitalizations among nonimmunocompromised children and adolescents aged 5-17 years - VISION Network, 10 states, April 2021-January 2022
    MMWR: Morbidity and Mortality Weekly Report. 2022
  • Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022
    MMWR: Morbidity and Mortality Weekly Report. 2022
  • Effectiveness of a third dose of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during oeriods of Delta and Omicron variant predominance - VISION Network, 10 states, August 2021-January 2022
    MMWR: Morbidity and Mortality Weekly Report. 2022
  • Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults-Nine States, January-September 2021
    American Journal of Transplantation. 2022
  • Estimation of COVID-19 mRNA vaccine effectiveness against medically attended COVID-19 in pregnancy during periods of Delta and Omicron variant predominance in the United States
    JAMA network open. 2022
  • Incidence of Guillain-Barré syndrome after COVID-19 vaccination in the Vaccine Safety Datalink
    JAMA network open. 2022
  • Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination
    Vaccine. 2022
  • Safety of COVID-19 vaccination in United States children ages 5 to 11 years
    Pediatrics. 2022
  • Waning 2-dose and 3-dose effectiveness of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron variant predominance - VISION Network, 10 states, August 2021-January 2022
    MMWR: Morbidity and Mortality Weekly Report. 2022
  • COVID-19 vaccination coverage among insured persons aged ≥16 years, by race/ethnicity and other selected characteristics - eight integrated health care organizations, United States, December 14, 2020-May 15, 2021
    MMWR: Morbidity and Mortality Weekly Report. 2021
  • Effectiveness of 2-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults - nine states, January-September 2021
    MMWR: Morbidity and Mortality Weekly Report. 2021
  • Effectiveness of Covid-19 vaccines in ambulatory and inpatient care settings
    New England Journal of Medicine. 2021
  • Laboratory-confirmed COVID-19 among adults hospitalized with COVID-19-like illness with infection-induced or mRNA vaccine-induced SARS-CoV-2 immunity - nine states, January-September 2021
    MMWR: Morbidity and Mortality Weekly Report. 2021
  • Surveillance for adverse events after COVID-19 mRNA vaccination
    JAMA. 2021
  • Safety of measles-containing vaccines in 1-year-old children
    Pediatrics. 2015
  • Effect of age on the risk of fever and seizures following immunization with measles-containing vaccines in children
    JAMA pediatrics. 2013
  • Guillain-Barre syndrome, influenza vaccination, and antecedent respiratory and gastrointestinal infections: a case-centered analysis in the Vaccine Safety Datalink, 2009-2011
    PloS One. 2013
  • Impact of specific glucose-control strategies on microvascular and macrovascular outcomes in 58,000 adults with type 2 diabetes
    Diabetes care. 2013
  • Super learning to hedge against incorrect inference from arbitrary parametric assumptions in marginal structural modeling
    Journal of Clinical Epidemiology. 2013
  • Dynamic marginal structural modeling to evaluate the comparative effectiveness of more or less aggressive treatment intensification strategies in adults with type 2 diabetes
    Pharmacoepidemiology and Drug Safety. 2012
  • Measles-containing vaccines and febrile seizures in children age 4 to 6 years
    Pediatrics. 2012
  • Safety of zoster vaccine in adults from a large managed-care cohort: a Vaccine Safety Datalink study
    Journal of Internal Medicine. 2012
  • ADHD medications and risk of serious cardiovascular events in young and middle-aged adults
    JAMA. 2011
  • H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project
    American Journal of Preventive Medicine. 2011
  • Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures
    Pediatrics. 2010
  • Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project
    American Journal of Epidemiology. 2010
  • Contact
    full name
  • B. H. Fireman
  • Quick Info
     
    Collaboration